Coverage
-
September 25, 2017
A Pennsylvania federal court dismissed Monday a health plan's potential class action accusing more than a dozen major drugmakers of fixing the prices of generic drugs, saying the plan couldn't have relied on the alleged misconduct of the drugmakers when deciding how much it owed providers based on its own experience.
1 other articles on this case.
View all »